Organigram Holdings Inc. (NASDAQ:OGI) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. lowered its position in shares of Organigram Holdings Inc. (NASDAQ:OGI) by 28.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 29,000 shares of the company’s stock after selling 11,611 shares during the quarter. Vontobel Holding Ltd.’s holdings in Organigram were worth $46,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Tidal Investments LLC increased its position in shares of Organigram by 8.3% in the third quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after acquiring an additional 149,171 shares in the last quarter. Clear Harbor Asset Management LLC grew its stake in shares of Organigram by 37.4% in the fourth quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company’s stock valued at $72,000 after buying an additional 12,250 shares in the last quarter. Finally, Toronto Dominion Bank lifted its position in Organigram by 803.7% during the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after acquiring an additional 14,876 shares in the last quarter. Institutional investors and hedge funds own 34.63% of the company’s stock.

Organigram Stock Up 1.6 %

OGI opened at $1.31 on Friday. The firm has a market capitalization of $165.35 million, a P/E ratio of -3.45 and a beta of 1.00. The firm’s 50 day moving average is $1.53 and its 200-day moving average is $1.65. Organigram Holdings Inc. has a 52-week low of $1.24 and a 52-week high of $2.91.

Organigram (NASDAQ:OGI) last announced its earnings results on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. Equities analysts expect that Organigram Holdings Inc. will post -0.19 earnings per share for the current fiscal year.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.